» Articles » PMID: 32201675

Minor Blood Group Incompatibility Due to Blood Groups Other Than Rh(D) Leading to Hemolytic Disease of Fetus and Newborn: a Need for Routine Antibody Screening During Pregnancy

Overview
Date 2020 Mar 24
PMID 32201675
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Minor blood group incompatibility due to blood groups other than Rh(D), although an uncommon cause of neonatal hyperbilirubinemia, has the potential to cause severe hyperbilirubinemia and its sequelae in infants, if left undiagnosed and untreated. Here, we describe clinical presentation, diagnosis and treatment of three cases of minor blood group incompatibility due to anti-E and anti-c antibody. All three neonates presented with pallor, icterus and splenomegaly within the first three days of life. Investigations showed indirect hyperbilirubinemia and a positive direct coombs test. Indirect coombs test was positive in the mothers. There was no setting of ABO or Rh(D) incompatibility in any of the neonates. When tested for minor blood group incompatibility, anti E antibody was found to be responsible for hemolysis and hyperbilirubinemia in the first case, and anti c antibody was found in the second case and third case had both anti c and anti E antibodies. While hyperbilirubinemia improved with intensive phototherapy in the first two cases, the third case required a double volume exchange transfusion. On follow up, bilateral sensorineural hearing loss was seen in one of the patients. All three neonates were otherwise healthy, gaining weight and developmentally normal.

Citing Articles

Patient experience and burden of haemolytic disease of the foetus and newborn: a systematic review.

Maurice P, McCallion J, Fitzgibbon M, Barthelmes J, Karmous W, Hardy E BMC Pregnancy Childbirth. 2025; 25(1):114.

PMID: 39905388 PMC: 11792410. DOI: 10.1186/s12884-025-07208-9.


Hemolytic disease of the fetus and newborn due to minor blood group alloimmunization in a mother of sickle cell disease with multiple alloantibodies.

Varghese S, Prakash S, Mukherjee S, Sahu A, Mishra D Asian J Transfus Sci. 2024; 17(2):291-294.

PMID: 38274971 PMC: 10807515. DOI: 10.4103/ajts.ajts_161_22.


Experience from an immunohematology reference testing center.

Mathur A, Prinja N, Srivalli A, Chakraboty S, Reddy T Asian J Transfus Sci. 2024; 17(2):301-304.

PMID: 38274952 PMC: 10807537. DOI: 10.4103/ajts.ajts_54_22.


Severe neonatal hyperbilirubinemia secondary to combined RhC hemolytic disease, congenital hypothyroidism and large adrenal hematoma: a case report.

Dai C, Chen C, Jiang L, Zhu Y, Wang C BMC Pediatr. 2022; 22(1):539.

PMID: 36089589 PMC: 9465864. DOI: 10.1186/s12887-022-03594-7.


Hemolytic Disease of the Newborn: A Review of Current Trends and Prospects.

Myle A, Al-Khattabi G Pediatric Health Med Ther. 2021; 12:491-498.

PMID: 34675752 PMC: 8504549. DOI: 10.2147/PHMT.S327032.

References
1.
Koelewijn J, Vrijkotte T, van der Schoot C, Bonsel G, de Haas M . Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion. 2008; 48(5):941-52. DOI: 10.1111/j.1537-2995.2007.01625.x. View

2.
Slootweg Y, Koelewijn J, van Kamp I, van der Bom J, Oepkes D, de Haas M . Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme. BJOG. 2015; 123(6):955-63. DOI: 10.1111/1471-0528.13816. View

3.
Moinuddin I, Fletcher C, Millward P . Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan. J Blood Med. 2019; 10:283-289. PMC: 6708388. DOI: 10.2147/JBM.S214118. View

4.
Roberts I . The changing face of haemolytic disease of the newborn. Early Hum Dev. 2008; 84(8):515-23. DOI: 10.1016/j.earlhumdev.2008.06.005. View

5.
. ACOG Practice Bulletin No. 192: Management of Alloimmunization During Pregnancy. Obstet Gynecol. 2018; 131(3):e82-e90. DOI: 10.1097/AOG.0000000000002528. View